Maki Fukami Selected Research

Gynecomastia

1/2021	Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
7/2014	Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis.
3/2014	Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
1/2014	Tamoxifen treatment for pubertal gynecomastia in two siblings with partial androgen insensitivity syndrome.
1/2012	Molecular bases and phenotypic determinants of aromatase excess syndrome.
6/2011	Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maki Fukami Research Topics

Disease

13	Hypospadias 12/2019 - 12/2006
9	Antley-Bixler Syndrome Phenotype 01/2018 - 01/2005
8	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2022 - 02/2006
8	Neoplasms (Cancer) 11/2020 - 01/2008
6	Gynecomastia 01/2021 - 06/2011
5	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2022 - 01/2014
5	Virilism (Virilization) 01/2021 - 05/2009
5	Pseudohypoparathyroidism 01/2021 - 01/2013
5	Precocious Puberty 01/2021 - 01/2015
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 01/2016
4	Cryptorchidism (Undescended Testes) 02/2018 - 08/2005
4	Azoospermia 01/2018 - 01/2014
4	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2017 - 12/2004
3	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism) 01/2022 - 05/2009
3	Gonadal Dysgenesis (Gonadal Agenesis) 01/2022 - 01/2012
3	Hyperphosphatemia 01/2021 - 01/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 05/2017
3	Leri-Weil syndrome 01/2019 - 10/2003
3	Androgen-Insensitivity Syndrome (Testicular Feminization) 02/2018 - 01/2014
3	Combined Pituitary Hormone Deficiency 01/2013 - 02/2010
3	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 12/2012 - 05/2009
2	Intellectual Disability (Idiocy) 05/2021 - 01/2015
2	Diabetes Mellitus 01/2021 - 01/2010
2	Hyperglycemia 01/2021 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 06/2018
2	Hypocalcemia 01/2021 - 01/2013
2	Congenital Hypothyroidism (Cretinism) 11/2020 - 04/2016
2	Megalencephaly 01/2020 - 05/2014
2	CHARGE Syndrome 06/2018 - 01/2018
2	Prader-Willi Syndrome (Syndrome, Prader-Willi) 02/2018 - 12/2017
2	Hypothyroidism 04/2016 - 01/2014
2	Hypoparathyroidism 12/2015 - 01/2010
2	Deafness (Deaf Mutism) 12/2015 - 01/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2014 - 01/2012
2	Penis agenesis 01/2014 - 02/2005
2	Kallmann Syndrome (Kallmann's Syndrome) 04/2006 - 08/2005
1	Imprinting Disorders 10/2022
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2022
1	Focal Dermal Hypoplasia (Syndrome, Goltz) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Congenital Disorders of Glycosylation 05/2021
1	SHORT syndrome 01/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Temple syndrome 01/2021

Drug/Important Bio-Agent (IBA)

11	SteroidsIBA 01/2021 - 12/2004
11	Testosterone (Sustanon)FDA Link 11/2020 - 12/2004
8	AndrogensIBA 01/2021 - 01/2012
8	Hormones (Hormone)IBA 01/2021 - 12/2004
7	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2005
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2009
5	EnzymesIBA 01/2022 - 12/2004
5	Estrogens (Estrogen)FDA Link 01/2022 - 08/2005
5	due to increased aromatase activity familial gynecomastiaIBA 01/2021 - 06/2011
5	DNA (Deoxyribonucleic Acid)IBA 07/2016 - 01/2009
4	Insulin (Novolin)FDA Link 01/2021 - 10/2008
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 12/2004
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021 - 12/2004
4	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 01/2019 - 10/2013
4	GonadotropinsIBA 12/2017 - 12/2004
4	Nonsense Codon (Nonsense Mutation)IBA 08/2017 - 12/2006
4	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2017 - 08/2005
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2014 - 01/2005
3	RNA Splice SitesIBA 01/2022 - 01/2018
3	NucleotidesIBA 01/2022 - 05/2017
3	AutoantibodiesIBA 01/2021 - 01/2010
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 08/2010
3	Phosphates (Orthophosphate)IBA 01/2019 - 01/2013
3	Growth Hormone (Somatotropin)IBA 06/2018 - 10/2008
3	GlucocorticoidsIBA 10/2016 - 10/2013
3	Aromatase (CYP19)IBA 07/2014 - 03/2014
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2022 - 10/2013
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2022 - 10/2013
2	SodiumIBA 01/2021 - 02/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2018
2	Pregnanolone (Allopregnanolone)IBA 01/2021 - 01/2016
2	Androstenedione (4 Androstene 3,17 dione)IBA 01/2021 - 11/2020
2	Parathyroid Hormone (Parathormone)IBA 01/2021 - 01/2018
2	Endocrine DisruptorsIBA 12/2019 - 08/2005
2	Blood Glucose (Blood Sugar)IBA 06/2018 - 01/2010
2	Androgen Receptors (Androgen Receptor)IBA 02/2018 - 01/2018
2	Dihydrotestosterone (Androstanolone)IBA 01/2018 - 07/2006
2	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 01/2016
2	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2018 - 01/2018
2	pregnanetrioloneIBA 04/2016 - 04/2012
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015 - 09/2012
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2015 - 12/2004
2	Biological ProductsIBA 12/2012 - 01/2012
2	Steroidogenic Factor 1IBA 10/2012 - 01/2009
2	bisphenol AIBA 01/2012 - 01/2012
2	Aromatase deficiencyIBA 05/2009 - 02/2006
1	SilverIBA 10/2022
1	Antithrombin IIIIBA 05/2021
1	Congenital disorder of glycosylation type 1AIBA 05/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	SymportersIBA 01/2021
1	CanagliflozinIBA 01/2021
1	NeurosteroidsIBA 01/2021

Therapy/Procedure

4	Therapeutics 01/2021 - 08/2005
3	Ligation 01/2016 - 01/2013